ART

Community Health Applied Research Network (CHARN)

  • Principal Investigator(s): Kenneth Mayer, MD
  • Study Contact: Kenneth Mayer, MD
  • Description of Subjects: Patients receiving primary care at participating community health centers across the U.S.
  • Location (Domestic vs. International): Boston, MA; greater MA; New England
  • Enrollment Period: 2007-2014
  • Enrollment Goal: >50,000

Cotrimoxazole safety study

  • Principal Investigator(s): Scott Dryden-Peterson
  • Study Contact: Scott Dryden-Peterson, +2.677.447.2522, scott_peterson@post.harvard.edu
  • Description of Subjects: Infants born to HIV-infected women
  • Location (Domestic vs. International): Botswana
  • Enrollment Period: 2008-2009
  • Enrollment Goal: 444 mother-infant pairs

Uganda AIDS Rural Treatment Outcomes Cohort Study

  • Principal Investigator(s): David Bangsberg, MD
  • Study Contact: Rachel Rifkin, 617.724.3194, rrifkin@partners.org
  • Description of Subjects: All patients over 18 years and initiating ART at the Mbarara Immune Suppression Syndrome Clinic who lived within 60 kilometers from the clinic
  • Location (Domestic vs. International): Mbarara, Uganda

Effect on CNS with ART switch off EFV-based therapy

  • Principal Investigator(s): Nina LIn
  • Study Contact:  Nina Lin, Tel: 617-768-8479, nhlin@partners.org
  • Description of Subjects:  Effect on CNS with ART switch off EFV-based therapy
  • Location (Domestic vs. International): Domestic, BWH (recruiting can be from MGH or BIDMC)
  • Enrollment Period: Beginning January 2014